Biofil Chemicals

{
  "main_header": {
    "sid": 386748,
    "name": "Biofil Chemicals",
    "stock_name": "Biofil Chemicals",
    "full_name": "Biofil Chemicals & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/biofil-chemicals",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "33.82",
    "chg": -1.03,
    "chgp": "-2.96%",
    "dir": -1,
    "prev_price": "34.85",
    "mcapval": "56.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524396,
    "symbol": "BIOFILCHEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE829A01014",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "18.22 k",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biofil-chemicals-386748-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-is-rated-sell-3977452",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiofilChemicals_mojoScore_3977452.png",
        "date": "2026-05-06 10:11:00",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-is-rated-sell-3956332",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BiofilChemicals_mojoScore_3956332.png",
        "date": "2026-04-22 10:10:51",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 April 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Biofil Chemicals Gains 14.91%: 2 Key Factors Driving the Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-gains-1491-2-key-factors-driving-the-weeks-rally-3943164",
        "imagepath": "",
        "date": "2026-04-11 17:11:26",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>6 Apr:</strong> Week opens at Rs.29.45</p>\n                    <p><strong>7 Apr:</strong> Stock hits upper circuit limit, closing at Rs.32.39 (+9.98%)</p>\n                    <p><strong>8 Apr:</strong> MarketsMOJO upgrades rating to Sell on improved technicals and valuation</p>\n                    <p><strong>10 Apr:</strong> Week closes at Rs.33.84 (+1.32%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.29.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.33.84</div><div class=\"s..."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd Upgraded to Sell on Improved Technicals and Valuation",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-upgraded-to-sell-on-improved-technicals-and-valuation-3936580",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BiofilChemicals_mojoScore_3936580.png",
        "date": "2026-04-08 08:15:01",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced improvement in technical indicators and valuation metrics despite ongoing fundamental challenges. The micro-cap pharmaceutical company’s recent price surge and valuation appeal have prompted this reassessment, though financial trends and quality scores remain subdued."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd Locks at Upper Circuit With 9.98% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-3935338",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BiofilChemicals_stocks_hitting_upper_circuit_3935338.png",
        "date": "2026-04-07 10:00:16",
        "description": "At Rs 32.28, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Biofil Chemicals & Pharmaceuticals Ltd locked at its upper circuit of 9.98% on 7 Apr 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-is-rated-strong-sell-3930077",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BiofilChemicals_mojoScore_3930077.png",
        "date": "2026-04-02 10:10:41",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd is rated 'Strong Sell' by MarketsMOJO. This rating was last updated on 16 February 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 02 April 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "Why is Biofil Chemicals & Pharmaceuticals Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-biofil-chemicals-pharmaceuticals-ltd-fallingrising-3926874",
        "imagepath": "",
        "date": "2026-03-31 01:36:49",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movements and Market Performance</strong></p>\n<p>The stock has been under significant pressure in recent weeks, with a one-week loss of 11.20% compared to the Sensex’s modest decline of 1.03%. Over the past month, Biofil Chemicals has fallen 15.76%, underperforming the benchmark index’s 10.33% drop. Year-to-date, the stock has declined nearly 25%, substantially worse than the Sensex’s 15.57% fall. This downward trend extends over longer periods as well, with the stock losing 37.69% in the last year and 61.17% over five years, while the Sensex has gained 43.50% during the same five-year span.</p>\n<p>On 30-Mar, the stock opened with a gap down of 5.96% and continued to slide throughout the day, hitting an intraday low of ₹25.60, which is also its new 52-week low. The weighted aver..."
      },
      {
        "title": "Markets Rally, But Biofil Chemicals & Pharmaceuticals Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-hits-52-week-low-amid-continued-downtrend-3924164",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BiofilChemicals_priceRelatedfactors_3924164.png",
        "date": "2026-03-30 10:02:37",
        "description": ""
      },
      {
        "title": "Markets Rally, But Biofil Chemicals & Pharmaceuticals Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-falls-to-52-week-low-of-rs2799-3919920",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BiofilChemicals_priceRelatedfactors_3919920.png",
        "date": "2026-03-27 14:11:10",
        "description": "Despite a broadly positive market environment, Biofil Chemicals & Pharmaceuticals Ltd has succumbed to selling pressure, hitting a fresh 52-week low of Rs 27.99 on 27 Mar 2026. This decline comes amid a sharp underperformance relative to the Sensex, which itself is hovering near its own 52-week lows."
      }
    ],
    "total": 176,
    "sid": "386748",
    "stock_news_url": "https://www.marketsmojo.com/news/biofil-chemicals-pharmaceuticals-386748"
  },
  "announcements": [
    {
      "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015-Intimation To The Shareholders Holding Shares In Physical Mode For Mandatory Furnishing Of PAN KYC Details Bank Account Details Nomination And Ot",
      "datetime": "05-May-2026",
      "details": "The Company hereby submit drafts intimation letter sent to holders of Physical shares of the company for updating PAN KYC Nomination and other details in accordance with applicable SEBI Circulars in terms of provisions of Reg.30 of SEBI (LODR) Regulations 2015 from time to time.",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "10-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Biofil Chemicals & Pharmaceuticals Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24233MP1985PLC002709</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.02</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Apoorv Jain <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: bcplcompliance@gmail.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Pavan Singh Rajput <br/> Designation: Chief Financial Officer <br/> EmailId: pawan90rajkam@gmail.com</div> </div> <div> <br/> Date: 10/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "03-Apr-2026",
      "details": "Submission of Publication in Newspaper pursuant to SEBI circular for Special Window for Transfer and Dematerialisation of Physcial Securities.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell

2026-05-06 10:11:00

Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell

2026-04-22 10:10:51

Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 April 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Biofil Chemicals Gains 14.91%: 2 Key Factors Driving the Week’s Rally

2026-04-11 17:11:26

Key Events This Week

6 Apr: Week opens at Rs.29.45

7 Apr: Stock hits upper circuit limit, closing at Rs.32.39 (+9.98%)

8 Apr: MarketsMOJO upgrades rating to Sell on improved technicals and valuation

10 Apr: Week closes at Rs.33.84 (+1.32%)

Week Open

Rs.29.45

Week Close

Rs.33.84

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd Upgraded to Sell on Improved Technicals and Valuation

2026-04-08 08:15:01

Biofil Chemicals & Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced improvement in technical indicators and valuation metrics despite ongoing fundamental challenges. The micro-cap pharmaceutical company’s recent price surge and valuation appeal have prompted this reassessment, though financial trends and quality scores remain subdued.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd Locks at Upper Circuit With 9.98% Gain — Buyers Queue, Sellers Absent

2026-04-07 10:00:16

At Rs 32.28, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Biofil Chemicals & Pharmaceuticals Ltd locked at its upper circuit of 9.98% on 7 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd is Rated Strong Sell

2026-04-02 10:10:41

Biofil Chemicals & Pharmaceuticals Ltd is rated 'Strong Sell' by MarketsMOJO. This rating was last updated on 16 February 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 02 April 2026, providing investors with the latest perspective on the company’s position.

Read full news article

Why is Biofil Chemicals & Pharmaceuticals Ltd falling/rising?

2026-03-31 01:36:49

Recent Price Movements and Market Performance

The stock has been under significant pressure in recent weeks, with a one-week loss of 11.20% compared to the Sensex’s modest decline of 1.03%. Over the past month, Biofil Chemicals has fallen 15.76%, underperforming the benchmark index’s 10.33% drop. Year-to-date, the stock has declined nearly 25%, substantially worse than the Sensex’s 15.57% fall. This downward trend extends over longer periods as well, with the stock losing 37.69% in the last year and 61.17% over five years, while the Sensex has gained 43.50% during the same five-year span.

On 30-Mar, the stock opened with a gap down of 5.96% and continued to slide throughout the day, hitting an intraday low of ₹25.60, which is also its new 52-week low. The weighted aver...

Read full news article

Markets Rally, But Biofil Chemicals & Pharmaceuticals Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-30 10:02:37

Read full news article

Markets Rally, But Biofil Chemicals & Pharmaceuticals Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-27 14:11:10

Despite a broadly positive market environment, Biofil Chemicals & Pharmaceuticals Ltd has succumbed to selling pressure, hitting a fresh 52-week low of Rs 27.99 on 27 Mar 2026. This decline comes amid a sharp underperformance relative to the Sensex, which itself is hovering near its own 52-week lows.

Read full news article

View All News